Antidepressant-Like Activity of Typical Antidepressant Drugs in the Forced Swim Test and Tail Suspension Test in Mice Is Augmented by DMPX, an Adenosine A2A Receptor Antagonist

[1]  P. Mäntyselkä,et al.  Purine metabolism is dysregulated in patients with major depressive disorder , 2016, Psychoneuroendocrinology.

[2]  P. Wlaź,et al.  Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice , 2016, Metabolic Brain Disease.

[3]  P. Wlaź,et al.  Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice , 2016, Pharmacological reports : PR.

[4]  P. Wlaź,et al.  Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice , 2015, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  P. Wlaź,et al.  The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice. , 2015, Life sciences.

[6]  C. Müller,et al.  Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress , 2015, Proceedings of the National Academy of Sciences.

[7]  C. Zarate,et al.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics , 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  P. Kale,et al.  Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice , 2014, Pharmacology Biochemistry and Behavior.

[9]  R. Cunha,et al.  Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety , 2014, Front. Psychiatry.

[10]  M. Merello,et al.  Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant , 2014, Expert opinion on pharmacotherapy.

[11]  P. Jenner,et al.  Antidepressant-like activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents , 2013, Pharmacology Biochemistry and Behavior.

[12]  J. Vetulani.  Early maternal separation: a rodent model of depression and a prevailing human condition , 2013, Pharmacological reports : PR.

[13]  G. Nowak,et al.  Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  J. Lanciego,et al.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease. , 2011, Pharmacology & therapeutics.

[15]  K. Hashimoto.  The role of glutamate on the action of antidepressants , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[16]  Christina L. Ruby,et al.  Adenosine Signaling in Anxiety , 2011 .

[17]  Catarina Gomes,et al.  Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. , 2011, Biochimica et biophysica acta.

[18]  G. Nowak,et al.  A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice , 2011, Journal of Neural Transmission.

[19]  B. Fredholm,et al.  Adenosine receptors as drug targets. , 2010, Experimental cell research.

[20]  Diogo R Lara,et al.  Caffeine, mental health, and psychiatric disorders. , 2010, Journal of Alzheimer's disease : JAD.

[21]  J. F. Chen,et al.  Adenosine, adenosine A 2A antagonists, and Parkinson's disease. , 2009, Parkinsonism & related disorders.

[22]  G. Nowak,et al.  The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[23]  Stafford L. Lightman,et al.  The HPA axis in major depression: classical theories and new developments , 2008, Trends in Neurosciences.

[24]  M. Schwab,et al.  Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation , 2008, Analytical and bioanalytical chemistry.

[25]  R. Cunha,et al.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. , 2008, Current pharmaceutical design.

[26]  R. Cunha.  Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity , 2008, Neurochemistry International.

[27]  P. Gillman.  Tricyclic antidepressant pharmacology and therapeutic drug interactions updated , 2007, British journal of pharmacology.

[28]  E. Poleszak.  Modulation of antidepressant-like activity of magnesium by serotonergic system , 2007, Journal of Neural Transmission.

[29]  S. Soelaiman,et al.  Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists , 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.

[30]  R. Cunha,et al.  Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress , 2006, Neuroscience.

[31]  G. Nowak,et al.  Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice , 2005, Pharmacology Biochemistry and Behavior.

[32]  P. Jenner,et al.  A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD , 2003, Neurology.

[33]  J. Costentin,et al.  Adenosine A2A receptors and depression , 2003, Neurology.

[34]  B. Balleine,et al.  Helplessness and escape performance: glutamate-adenosine interactions in the frontal cortex. , 2003, Behavioral neuroscience.

[35]  G. Nowak,et al.  Interaction of zinc with antidepressants in the forced swimming test in mice. , 2002, Polish journal of pharmacology.

[36]  M. Aomine,et al.  Modulation of the stress response by coffee: an in vivo microdialysis study of hippocampal serotonin and dopamine levels in rat , 2002, Neuroscience Letters.

[37]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[38]  E. Ongini,et al.  Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice , 2001, British journal of pharmacology.

[39]  M. Berk,et al.  Blunted adenosine A2a receptor function in platelets in patients with major depression , 2001, European Neuropsychopharmacology.

[40]  Carmine M Pariante,et al.  Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment , 2001, Biological Psychiatry.

[41]  D. Nutt,et al.  Adenosine Receptor Subtypes Modulate Two Major Functional Pathways for Hippocampal Serotonin Release , 2001, The Journal of Neuroscience.

[42]  A. Chédotal,et al.  Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor , 2000, Nature.

[43]  Wyeth Wasserman,et al.  Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[44]  P. Delgado.  Depression: the case for a monoamine deficiency. , 2000, The Journal of clinical psychiatry.

[45]  G. Stiles,et al.  The role of receptor structure in determining adenosine receptor activity. , 2000, Pharmacology & therapeutics.

[46]  S. Preskorn,et al.  Therapeutic Drug Monitoring of Antidepressants , 1999 .

[47]  J. Rose,et al.  Adenosine modulates corticotropin and cortisol release during hypoxia in fetal sheep. , 1999, American journal of obstetrics and gynecology.

[48]  B. Fredholm,et al.  Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. , 1999, Pharmacological reviews.

[49]  J. Linden,et al.  Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system , 1998, The Journal of comparative neurology.

[50]  L. Agnati,et al.  Postnatal maternal separation during the stress hyporesponsive period enhances the adrenocortical response to novelty in adult rats by affecting feedback regulation in the CA1 hippocampal field , 1998, International Journal of Developmental Neuroscience.

[51]  S. Caccia.  Metabolism of the Newer Antidepressants , 1998, Clinical pharmacokinetics.

[52]  B B Fredholm,et al.  Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic study , 1997, Synapse.

[53]  Sergi Ferré,et al.  Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia , 1997, Trends in Neurosciences.

[54]  P. Svenningsson,et al.  Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas , 1997, Neuroscience.

[55]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[56]  A. Gubitz,et al.  Tissue distribution of adenosine receptor mRNAs in the rat , 1996, British journal of pharmacology.

[57]  U. Ungerstedt,et al.  Dopamine D1 Receptor‐mediated Facilitation of GABAergic Neurotransmission in the Rat Strioentopeduncular Pathway and its Modulation by Adenosine A1 Receptor‐mediated Mechanisms , 1996, The European journal of neuroscience.

[58]  K. Fuxe,et al.  Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites , 1996, Neuroscience Letters.

[59]  J. Ribeiro,et al.  Adenosine A2 receptor-mediated excitatory actions on the nervous system , 1996, Progress in Neurobiology.

[60]  T. Palmer,et al.  Adenosine receptors , 1995, Neuropharmacology.

[61]  M. Lazdunski,et al.  Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[62]  F. Holsboer,et al.  Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. , 1994, Neuroendocrinology.

[63]  J. L. Winslow,et al.  Stress and adenosine: II. Adenosine analogs mimic the effect of inescapable shock on shuttle-escape performance in rats. , 1994, Behavioral neuroscience.

[64]  F. Holsboer,et al.  Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. , 1993, Endocrinology.

[65]  K. Fuxe,et al.  Adenosine-dopamine interactions in the brain , 1992, Neuroscience.

[66]  K. Fuxe,et al.  Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum , 1992, Brain Research.

[67]  E. M. Adler,et al.  Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. , 1992, Brain research. Molecular brain research.

[68]  S. Schiffmann,et al.  Distribution of adenosine A2 receptor mRNA in the human brain , 1991, Neuroscience Letters.

[69]  S. Schiffmann,et al.  Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study , 1991, Journal of neurochemistry.

[70]  J. Linden.  Structure and function of A 1 adenosine receptors1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[71]  C. Gerfen,et al.  Cloning and expression of an A1 adenosine receptor from rat brain. , 1991, Molecular pharmacology.

[72]  S. Scaccianoce,et al.  Adenosine and pituitary-adrenocortical axis activity in the rat. , 1989, Neuroendocrinology.

[73]  K. Starke.  The beginnings of hirudin. , 1989, Trends in pharmacological sciences.

[74]  A. Prochiantz,et al.  Inhibition of brain adenylate cyclase by A1 adenosine receptors: Pharmacological characteristics and locations , 1983, Brain Research.

[75]  R. Porsolt,et al.  Behavioral despair in mice: a primary screening test for antidepressants. , 1977, Archives internationales de pharmacodynamie et de therapie.

[76]  H. Akiskal,et al.  Depressive Disorders: Toward a Unified Hypothesis , 1973, Science.

[77]  J. Dudka,et al.  Chronic treatment with caffeine and its withdrawal modify the antidepressant‐like activity of selective serotonin reuptake inhibitors in the forced swim and tail suspension tests in mice. Effects on Comt, Slc6a15 and Adora1 gene expression , 2017, Toxicology and applied pharmacology.

[78]  Koji Yamada,et al.  Involvement of adenosine A2A receptors in depression and anxiety. , 2014, International review of neurobiology.

[79]  C. Duman.  Models of depression. , 2010, Vitamins and hormones.

[80]  Ana M Sebastião,et al.  Adenosine receptors and the central nervous system. , 2009, Handbook of experimental pharmacology.

[81]  F. Guengerich.  Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.

[82]  B. Fredholm,et al.  Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. , 2005, Annual review of pharmacology and toxicology.

[83]  P. Svenningsson,et al.  Adenosine and brain function. , 2005, International review of neurobiology.

[84]  S. Kulkarni,et al.  Purine nucleoside — mediated immobility in mice: Reversal by antidepressants , 2004, Psychopharmacology.

[85]  L. Maltais,et al.  Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. , 2004, Pharmacogenetics.

[86]  B. Thierry,et al.  The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.

[87]  R. Baldessarini,et al.  Suicidal Behaviour in Bipolar Disorder , 2003, CNS drugs.

[88]  T. Palmer,et al.  Adenosine receptors. , 1995, Neuropharmacology.

[89]  A. Tucker,et al.  Molecular cloning of adenosine A1 and A2 receptors. , 1991, Trends in pharmacological sciences.

[90]  C. Gleiter,et al.  Adenosinergic psychopharmaceuticals? , 1989, TIPS - Trends in Pharmacological Sciences.